GRASS is a clinical research trial being conducted at Royal Brompton Hospital and Imperial College, London.
The trial is led by Professor Stephen Durham, MD, a leading specialist in allergies. The GRASS trial is sponsored by the University of California, San Francisco and conducted by the Immune Tolerance Network (ITN) a non-profit consortium of doctors and scientists dedicated to finding new treatments for autoimmune disease, transplant rejection and allergy. The ITN is supported by the National Institute of Allergy and Infectious Diseases (NIAID), an institute of the U.S. National Institutes of Health.
Stephen Durham, MD , is renowned as a leading specialist in allergies. He is Head of the Section of Allergy & Clinical Immunology at Imperial College London and the Clinical Lead for allergy services at Royal Brompton and Harefield Hospitals. He is committed to running a high quality NHS Allergy Service and improving quality of life of allergy sufferers. He leads a world class research group that performs translational (bench to bedside) research focused on developing and improving treatments for hay fever and asthma. He has a special interest in allergen immunotherapy, a treatment that not only treats the symptoms of hay fever but has potential to induce long-term disease remission.